HIV-2 Infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HIV-2 Infection trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07563309

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

The objectives of this study are as follows: To evaluate the clinical performance of the TruPlex test using capillary blood, EDTA whole blood, EDTA plasma, and…

South Africa1,000 participantsStarted 2025-12-18

Treatment: TruPlex HIV/HepB/Syphilis Rapid Test

RecruitingNot Applicable

NCT05215704

Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV

Combination antiretroviral therapy (cART) blocks intracellular human immunodeficiency virus (HIV) replication in CD4+ T-lymphocytes, but fails to eliminate late…

Netherlands40 participantsStarted 2012-01-01

All recent trials (15 shown)

Not Yet RecruitingNot Applicable

NCT07569913

A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test

To evaluate the clinical performance of each analyte (HIV, HBsAg, and Syphilis) on the TruPlex HIV/HepB/Syphilis Rapid Test (TruPlex Test) using capillary blood…

Australia500 participantsStarted 2026-09-01

Treatment: TruPlex HIV/HepB/Syphilis Rapid Test

CompletedPhase 2

NCT01605890

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patien…

The HIV-2 is less common ie 1-2 million people in West Africa. HIV-2 does have the same sensitivity to antiretroviral treatment (ART) compared to HIV-1. The ART…

France30 participantsStarted 2012-07

Treatment: emtricitabine / tenofovir disoproxil fumarate / raltegravir .

HIV-2 Infection

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV

All recent trials (15 shown)

A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patien…

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV

All recent trials (15 shown)

A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patien…

Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol

A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands

RESIST-2: 2nd-line ART for HIV-2 Infection

Cohorte Nationale VIH-2

Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects

First-Line Treatment for HIV-2

An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal

Probiotic Visbiome for Inflammation and Translocation in HIV II

Retrovirus Epidemiology Donor Study I (REDS I)

Retrovirus Epidemiology Donor Study-II (REDS-II)

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients